10x Genomics, Inc.
TXG
$18.81
$0.060.32%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -1.75% | 12.93% | 9.84% | -10.30% | -1.30% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -1.75% | 12.93% | 9.84% | -10.30% | -1.30% |
| Cost of Revenue | 7.59% | -2.99% | 3.44% | -20.72% | -22.12% |
| Gross Profit | -5.72% | 20.40% | 13.12% | -4.17% | 11.37% |
| SG&A Expenses | -8.63% | -12.44% | 5.97% | 5.53% | -0.86% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -6.52% | -8.92% | 1.50% | -1.34% | -6.71% |
| Operating Income | 23.97% | 89.09% | 18.30% | -47.47% | 22.30% |
| Income Before Tax | 18.10% | 199.78% | 42.03% | -3.82% | 62.46% |
| Income Tax Expenses | -155.74% | 200.61% | -60.30% | -72.47% | 5.88% |
| Earnings from Continuing Operations | 23.16% | 191.14% | 42.69% | -0.16% | 61.55% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 23.16% | 191.14% | 42.69% | -0.16% | 61.55% |
| EBIT | 23.97% | 89.09% | 18.30% | -47.47% | 22.30% |
| EBITDA | 34.67% | 109.96% | 19.32% | -70.65% | 26.12% |
| EPS Basic | 26.07% | 188.43% | 44.19% | 2.35% | 62.51% |
| Normalized Basic EPS | 26.25% | 106.06% | 25.34% | -87.27% | 30.95% |
| EPS Diluted | 26.07% | 187.22% | 44.19% | 2.35% | 62.51% |
| Normalized Diluted EPS | 26.25% | 106.01% | 25.34% | -87.27% | 30.95% |
| Average Basic Shares Outstanding | 3.95% | 3.07% | 2.69% | 2.56% | 2.55% |
| Average Diluted Shares Outstanding | 3.95% | 3.70% | 2.69% | 2.56% | 2.55% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |